RapamycinFungusV1, Main, Corpus, bibRecord, 000E91

Hepatitis C virus infection and insulin resistance.

Identifieur interne : 000E91 ( Main/Corpus ); précédent : 000E90; suivant : 000E92

Hepatitis C virus infection and insulin resistance.

Auteurs : Sandip K. Bose ; Ranjit Ray

Source :

World journal of diabetes [ 1948-9358 ] ; 2014.

RBID : pubmed:24567801

Abstract

Approximately 170 million people worldwide are chronically infected with hepatitis C virus (HCV). Chronic HCV infection is the leading cause for the development of liver fibrosis, cirrhosis, hepatocellular carcinoma (HCC) and is the primary cause for liver transplantation in the western world. Insulin resistance is one of the pathological features in patients with HCV infection and often leads to development of type II diabetes. Insulin resistance plays an important role in the development of various complications associated with HCV infection. Recent evidence indicates that HCV associated insulin resistance may result in hepatic fibrosis, steatosis, HCC and resistance to anti-viral treatment. Thus, HCV associated insulin resistance is a therapeutic target at any stage of HCV infection. HCV modulates normal cellular gene expression and interferes with the insulin signaling pathway. Various mechanisms have been proposed in regard to HCV mediated insulin resistance, involving up regulation of inflammatory cytokines, like tumor necrosis factor-α, phosphorylation of insulin-receptor substrate-1, Akt, up-regulation of gluconeogenic genes like glucose 6 phosphatase, phosphoenolpyruvate carboxykinase 2, and accumulation of lipid droplets. In this review, we summarize the available information on how HCV infection interferes with insulin signaling pathways resulting in insulin resistance.

DOI: 10.4239/wjd.v5.i1.52
PubMed: 24567801
PubMed Central: PMC3932427

Links to Exploration step

pubmed:24567801

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hepatitis C virus infection and insulin resistance.</title>
<author><name sortKey="Bose, Sandip K" sort="Bose, Sandip K" uniqKey="Bose S" first="Sandip K" last="Bose">Sandip K. Bose</name>
<affiliation><nlm:affiliation>Sandip K Bose, Ranjit Ray, Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, United States.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ray, Ranjit" sort="Ray, Ranjit" uniqKey="Ray R" first="Ranjit" last="Ray">Ranjit Ray</name>
<affiliation><nlm:affiliation>Sandip K Bose, Ranjit Ray, Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, United States.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24567801</idno>
<idno type="pmid">24567801</idno>
<idno type="doi">10.4239/wjd.v5.i1.52</idno>
<idno type="pmc">PMC3932427</idno>
<idno type="wicri:Area/Main/Corpus">000E91</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E91</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hepatitis C virus infection and insulin resistance.</title>
<author><name sortKey="Bose, Sandip K" sort="Bose, Sandip K" uniqKey="Bose S" first="Sandip K" last="Bose">Sandip K. Bose</name>
<affiliation><nlm:affiliation>Sandip K Bose, Ranjit Ray, Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, United States.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ray, Ranjit" sort="Ray, Ranjit" uniqKey="Ray R" first="Ranjit" last="Ray">Ranjit Ray</name>
<affiliation><nlm:affiliation>Sandip K Bose, Ranjit Ray, Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, United States.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">World journal of diabetes</title>
<idno type="ISSN">1948-9358</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Approximately 170 million people worldwide are chronically infected with hepatitis C virus (HCV). Chronic HCV infection is the leading cause for the development of liver fibrosis, cirrhosis, hepatocellular carcinoma (HCC) and is the primary cause for liver transplantation in the western world. Insulin resistance is one of the pathological features in patients with HCV infection and often leads to development of type II diabetes. Insulin resistance plays an important role in the development of various complications associated with HCV infection. Recent evidence indicates that HCV associated insulin resistance may result in hepatic fibrosis, steatosis, HCC and resistance to anti-viral treatment. Thus, HCV associated insulin resistance is a therapeutic target at any stage of HCV infection. HCV modulates normal cellular gene expression and interferes with the insulin signaling pathway. Various mechanisms have been proposed in regard to HCV mediated insulin resistance, involving up regulation of inflammatory cytokines, like tumor necrosis factor-α, phosphorylation of insulin-receptor substrate-1, Akt, up-regulation of gluconeogenic genes like glucose 6 phosphatase, phosphoenolpyruvate carboxykinase 2, and accumulation of lipid droplets. In this review, we summarize the available information on how HCV infection interferes with insulin signaling pathways resulting in insulin resistance. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24567801</PMID>
<DateCompleted><Year>2014</Year>
<Month>06</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1948-9358</ISSN>
<JournalIssue CitedMedium="Print"><Volume>5</Volume>
<Issue>1</Issue>
<PubDate><Year>2014</Year>
<Month>Feb</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>World journal of diabetes</Title>
<ISOAbbreviation>World J Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>Hepatitis C virus infection and insulin resistance.</ArticleTitle>
<Pagination><MedlinePgn>52-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4239/wjd.v5.i1.52</ELocationID>
<Abstract><AbstractText>Approximately 170 million people worldwide are chronically infected with hepatitis C virus (HCV). Chronic HCV infection is the leading cause for the development of liver fibrosis, cirrhosis, hepatocellular carcinoma (HCC) and is the primary cause for liver transplantation in the western world. Insulin resistance is one of the pathological features in patients with HCV infection and often leads to development of type II diabetes. Insulin resistance plays an important role in the development of various complications associated with HCV infection. Recent evidence indicates that HCV associated insulin resistance may result in hepatic fibrosis, steatosis, HCC and resistance to anti-viral treatment. Thus, HCV associated insulin resistance is a therapeutic target at any stage of HCV infection. HCV modulates normal cellular gene expression and interferes with the insulin signaling pathway. Various mechanisms have been proposed in regard to HCV mediated insulin resistance, involving up regulation of inflammatory cytokines, like tumor necrosis factor-α, phosphorylation of insulin-receptor substrate-1, Akt, up-regulation of gluconeogenic genes like glucose 6 phosphatase, phosphoenolpyruvate carboxykinase 2, and accumulation of lipid droplets. In this review, we summarize the available information on how HCV infection interferes with insulin signaling pathways resulting in insulin resistance. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bose</LastName>
<ForeName>Sandip K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo><Affiliation>Sandip K Bose, Ranjit Ray, Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ray</LastName>
<ForeName>Ranjit</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Sandip K Bose, Ranjit Ray, Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>World J Diabetes</MedlineTA>
<NlmUniqueID>101547524</NlmUniqueID>
<ISSNLinking>1948-9358</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-viral therapy</Keyword>
<Keyword MajorTopicYN="N">Glucose transporter-4</Keyword>
<Keyword MajorTopicYN="N">Hepatitis C virus</Keyword>
<Keyword MajorTopicYN="N">Insulin receptor substrate 1</Keyword>
<Keyword MajorTopicYN="N">Insulin resistance</Keyword>
<Keyword MajorTopicYN="N">Lipid metabolism</Keyword>
<Keyword MajorTopicYN="N">Protein kinase B</Keyword>
<Keyword MajorTopicYN="N">Suppressor of cytokine signaling 3</Keyword>
<Keyword MajorTopicYN="N">mammalian target of rapamycin/S6K1</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>11</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>12</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>01</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24567801</ArticleId>
<ArticleId IdType="doi">10.4239/wjd.v5.i1.52</ArticleId>
<ArticleId IdType="pmc">PMC3932427</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Gastroenterol Hepatol. 2010 Mar;25(3):627-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20074151</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 1999 Apr;103(7):931-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10194465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hepatol. 2008 Aug;49(2):295-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18555553</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Endocrinol Metab. 2001 Feb;86(2):713-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11158035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2000 Aug;106(4):453-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10953019</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1989 Apr 21;57(2):305-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2649253</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2011 Jul 11;8:346</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21745397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Obes Relat Metab Disord. 2000 Nov;24 Suppl 4:S28-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11126236</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2013 Aug 28;310(8):804-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23982366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2013 Oct-Dec;7(4):238-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24290092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1199-202</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10563526</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetologia. 2006 Aug;49(8):1732-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16718463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hepatology. 2009 Dec;50(6):1702-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19845037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Intern Med. 1994 Mar;235(3):283-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8120528</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Biosci. 2003 May 01;8:s401-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12700047</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Sep;85(17 ):8556-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21697492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Viral Hepat. 2012 Jan;19 Suppl 1:42-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22233413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Endocrinol. 2009 Oct;203(1):1-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19389739</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hepatol. 2012 Apr;56(4):862-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22173166</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hepatology. 2002 Nov;36(5 Suppl 1):S21-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12407573</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microb Comp Genomics. 2000;5(3):129-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11252351</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gut. 2005 May;54(5):682-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15831916</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1998 Feb 26;391(6670):900-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9495343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Mar;82(6):2606-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18160431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hepatology. 2004 Jan;39(1):179-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14752836</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 May 13;100(10):6104-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12719519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hepatol. 2010 May;52(5):635-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20347177</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1989 Apr;86(8):2535-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2649883</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Liver Dis. 2011 May;15(2):281-96, vii-x</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21689613</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2011 Mar 31;364(13):1207-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21449784</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Cell Immunol. 2013;Suppl 1(11):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24319628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Biol Med (Maywood). 2001 Jan;226(1):13-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11368233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Metab. 2011 Jul 6;14(1):9-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21723500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1994 Nov 10;372(6502):182-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7969452</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>World J Gastroenterol. 2012 Jan 21;18(3):212-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22294824</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2001 May;7(5):710-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11350035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Viral Hepat. 2012 Jul;19(7):480-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22676360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:52-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16225474</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hepatology. 2008 Jun;47(6):2127-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18446789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Jun;86(11):6315-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22457523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hepatology. 2001 Jun;33(6):1358-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11391523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Jun;84(12 ):5936-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20357092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2004 Nov;165(5):1499-508</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15509521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2011 Jun 23;364(25):2405-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21696307</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Med Chem. 2008;15(13):1316-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18537611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2007 Apr 20;355(4):883-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17331464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Liver Dis. 2000;20(1):17-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10895429</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Gastroenterol. 2007 Mar;102(3):570-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17222321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gastroenterology. 2008 Feb;134(2):416-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18164296</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2011 Nov 01;8:496</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22044490</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 1996 Sep;19(9):998-1000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8875096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Postgrad Med. 2012 Nov;124(6):82-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23322141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dig Dis Sci. 2002 Apr;47(4):710-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11991597</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2002 Feb;16(2):185-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11818366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Biochem Rev. 2005 May;26(2):19-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16278749</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>World J Gastroenterol. 2010 Apr 28;16(16):1943-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20419831</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 1998 Sep;4(9):1065-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9734402</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gastroenterology. 2004 Mar;126(3):840-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14988838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1997 Jan 30;336(5):347-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9011789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E906-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12959938</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>QJM. 2005 Jan;98(1):1-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15625348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hepatology. 2007 May;45(5):1164-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17465001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2012 Mar 2;148(5):852-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22385956</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hepatol. 2008 May;48(5):721-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18308416</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E91 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000E91 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:24567801
   |texte=   Hepatitis C virus infection and insulin resistance.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:24567801" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020

	Serveur d'exploration sur la rapamycine et les champignons
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la rapamycine et les champignons

Hepatitis C virus infection and insulin resistance.

Hepatitis C virus infection and insulin resistance.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki